15 Of The Most Popular ADHD Medication Pregnancy Bloggers You Must Follow
ADHD Medication During Pregnancy and Breastfeeding
Women suffering from ADHD face a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breastfeeding. There is a lack of information about how long-term exposure to these drugs may affect the foetus.
A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in utero do not develop neurological conditions like hearing or vision impairment, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality research.
Risk/Benefit Analysis
Women who are pregnant and taking ADHD medication must evaluate the benefits of using it against the possible risks for the baby. The doctors don't have the information to provide clear recommendations however they can provide information about risks and benefits to assist pregnant women to make informed choices.
A study published in Molecular Psychiatry found that women who were taking ADHD medications in early pregnancy did not have an increased risk of fetal cardiac malformations or major structural birth defects. Researchers conducted a large population-based case control study to examine the prevalence of major structural defects in infants who were born to mothers who took stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts looked over the cases to make sure that the classification was correct and to eliminate any bias.
However, the study was not without its flaws. The researchers were not able in the beginning, to separate the effects caused by the medication from the disorder. That limitation makes it difficult to determine whether the limited associations observed in the exposed groups result from medication use or comorbidities that cause confusion. Researchers also did not look at long-term outcomes for the offspring.
The study showed that infants whose mother had taken ADHD medication during pregnancy were at a slightly greater risk of being admitted to the neonatal care unit (NICU) in comparison to those whose mothers didn't take any medication during pregnancy or discontinued taking their medication prior to or during pregnancy. The reason for this was central nervous system-related disorders, and the increased risk for admission was not found to be affected by the type of stimulant medication was used during pregnancy.
Women who were taking stimulant ADHD medications during pregnancy also had a higher risk of having a caesarean section or one whose baby scored low on the Apgar scale (less than 7). These increases appeared to be independent of the type of medication used during pregnancy.
Researchers suggest that the minor risk of using ADHD medication during pregnancies in the early stages may be offset by the more beneficial outcomes for both baby and mother of continued treatment for the woman's condition. Physicians should speak with their patients about this issue and as much as possible, assist them develop coping skills that could reduce the impact of her disorder in her daily life and relationships.
Medication Interactions
As more women than ever are diagnosed with ADHD and being treated with medication, the question of whether to keep or end treatment during pregnancy is one that more and more physicians have to face. The majority of these decisions are made without clear and authoritative evidence either way, so physicians must weigh what they know, the experiences of other doctors, and what the research suggests on the subject as well as their own best medication for adhd and anxiety judgment for each individual patient.
The issue of potential risks to the infant can be particularly tricky. The research on this subject is based on observations instead of controlled studies and many of the findings are contradictory. The majority of studies restrict their analysis to live-births, which adhd medication is the best could underestimate the teratogenic impact leading to abortions or terminations of pregnancy. The study discussed in the journal club addresses these issues, by examining both information on deceased and live births.
The conclusion The conclusion: While some studies have shown a positive association between most popular adhd medication medications and the possibility of certain birth defects, other studies have not found any evidence of a link and the majority of studies have a neutral or slightly negative effect. In every case it is imperative to conduct a thorough evaluation of the potential risks and benefits is required.
It can be difficult, if not impossible for women with ADHD to stop taking their medication. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of isolation. In addition, a decrease in medication can affect the ability to complete work-related tasks and safely drive, which are important aspects of a normal life for many people with ADHD.
She suggests that women who are unsure whether to continue taking the medication or stop it due to their pregnancy should educate family members, coworkers and their friends about the condition, its impact on daily functioning and the benefits of keeping the current treatment plan. In addition, educating them can aid in ensuring that the woman feels supported in her struggle with her decision. Some medications can pass through the placenta. If a patient decides to stop taking her inattentive adhd medication medication while pregnant and breastfeeding, it is important to be aware that the drug could be transferred to the baby.
Birth Defects and Risk of
As the use and abuse of ADHD medication to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD), increases, so does concern about the potential adverse effects of the drugs on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this subject. Utilizing two huge data sets researchers were able analyze more than 4.3 million pregnancies and see whether stimulant medications increased the risk of birth defects. Researchers found that while the overall risk is low, the first trimester intuitive adhd medication medication exposure was associated with slightly higher rates of specific heart defects like ventriculoseptal defects.
The authors of the study found no connection between early medication use and other congenital anomalies, such as facial clefting or club foot. The results are consistent with previous studies showing a small but significant increase in the risk of developing cardiac malformations among women who began taking ADHD medications prior to the birth of their child. This risk increased during the latter half of pregnancy, when a lot of women stopped taking their medication.
Women who were taking ADHD medication during the first trimester were more likely to require a caesarean birth, have a low Apgar after delivery and have a baby who needed breathing assistance at birth. However the authors of the study were unable to eliminate bias due to selection by limiting the study to women who did not have any other medical issues that could be a contributing factor to these findings.
The researchers hope that their research will help inform the clinical decisions of physicians who see pregnant women. They advise that while the discussion of risks and benefits is important but the decision to stop or maintain medication should be based on each woman's requirements and the severity of her ADHD symptoms.
The authors caution that, while stopping the medication is an option to look into, it is not advised due to the high rate depression and other mental disorders for women who are pregnant or recently gave birth. Research has also shown that women who stop taking their medications will have a harder transitioning to life without them once the baby is born.
Nursing
It can be a challenge becoming a mother. Women who suffer from adhd medication online uk are often faced with a number of difficulties when they have to manage their symptoms, attend doctor appointments, prepare for the birth of their child and adjust to a new routine. Many women opt to continue taking their ADHD medication during pregnancy.
The risk for breastfeeding infant is not too high since the majority of stimulant medication passes through breast milk at low levels. However, the frequency of exposure to medications by the newborn can vary depending on dosage, frequency it is taken and the time of the day it is administered. Additionally, different drugs enter the infant's system through the gastrointestinal tract or through breast milk. The impact on the health of a newborn isn't fully comprehended.
Some doctors may decide to stop stimulant medication during a woman’s pregnancy due to the absence of research. It's a difficult choice for the woman who must weigh the advantages of taking her medication as well as the risk to the embryo. As long as there is no more information, doctors should ask all pregnant patients about their history of ADHD and whether they are planning or taking to take medication during the perinatal period.
A increasing number of studies have proven that the majority of women are able to safely continue their ADHD medication while they are pregnant and nursing. In response, an increasing number of patients are opting to continue their medication. They have discovered through consultation with their doctors that the benefits of retaining their current medication outweigh potential risks.
Women who suffer from ADHD who are planning to breastfeed should seek the advice of a specialist psychiatrist before becoming pregnant. They should discuss the medication they are taking with their physician, and the pros and cons of continuing treatment. This includes non-pharmacological methods. Psychoeducation should also be offered to help pregnant people with ADHD recognize their symptoms and the root cause, learn about available treatment options and strengthen existing strategies for coping. This should be a multidisciplinary approach together with obstetricians, GPs, and psychiatry. Pregnancy counseling should include discussion of a treatment plan for the mother and the child, monitoring of indicators of deterioration, and, if needed adjustments to the medication regimen.